518 related articles for article (PubMed ID: 21309672)
41. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
Beaugerie L; Sokol H; Seksik P
Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
[TBL] [Abstract][Full Text] [Related]
42. Pathology of dysplasia and cancer in inflammatory bowel disease.
Mescoli C; Frego M; Rugge M
Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
[TBL] [Abstract][Full Text] [Related]
43. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Subramanian V; Logan RF
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
[TBL] [Abstract][Full Text] [Related]
44. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
45. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
46. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
47. Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions.
Konda A; Duffy MC
Gastroenterol Clin North Am; 2008 Mar; 37(1):191-213, viii. PubMed ID: 18313546
[TBL] [Abstract][Full Text] [Related]
48. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
49. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
51. Prevention of cancer in IBD - a balancing act.
Mill J; Lawrance IC
Minerva Gastroenterol Dietol; 2013 Sep; 59(3):261-72. PubMed ID: 23867946
[TBL] [Abstract][Full Text] [Related]
52. Colitis and colorectal cancer.
Foersch S; Waldner MJ; Neurath MF
Dig Dis; 2012; 30(5):469-76. PubMed ID: 23108302
[TBL] [Abstract][Full Text] [Related]
53. Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective.
Rutter MD; Riddell RH
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):359-67. PubMed ID: 23756224
[TBL] [Abstract][Full Text] [Related]
54. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
[TBL] [Abstract][Full Text] [Related]
55. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Soetikno R; Sanduleanu S; Kaltenbach T
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):483-520. PubMed ID: 24975538
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer in idiopathic inflammatory bowel disease.
Harpaz N; Talbot IC
Semin Diagn Pathol; 1996 Nov; 13(4):339-57. PubMed ID: 8946611
[TBL] [Abstract][Full Text] [Related]
57. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
[TBL] [Abstract][Full Text] [Related]
58. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
59. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
[TBL] [Abstract][Full Text] [Related]
60. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
